These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 15959838)

  • 1. Traumatic brain injury: cause or risk of Alzheimer's disease? A review of experimental studies.
    Szczygielski J; Mautes A; Steudel WI; Falkai P; Bayer TA; Wirths O
    J Neural Transm (Vienna); 2005 Nov; 112(11):1547-64. PubMed ID: 15959838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
    Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
    Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice.
    Schuessel K; Schäfer S; Bayer TA; Czech C; Pradier L; Müller-Spahn F; Müller WE; Eckert A
    Neurobiol Dis; 2005 Feb; 18(1):89-99. PubMed ID: 15649699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head injury and dementia.
    Jellinger KA
    Curr Opin Neurol; 2004 Dec; 17(6):719-23. PubMed ID: 15542981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender dependent APP processing in a transgenic mouse model of Alzheimer's disease.
    Schäfer S; Wirths O; Multhaup G; Bayer TA
    J Neural Transm (Vienna); 2007 Mar; 114(3):387-94. PubMed ID: 17075721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging, cortical injury and Alzheimer's disease-like pathology in the guinea pig brain.
    Bates K; Vink R; Martins R; Harvey A
    Neurobiol Aging; 2014 Jun; 35(6):1345-51. PubMed ID: 24360504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic analysis of response to traumatic brain injury in a mouse model of Alzheimer's disease (APPsw).
    Crawford FC; Wood M; Ferguson S; Mathura VS; Faza B; Wilson S; Fan T; O'Steen B; Ait-Ghezala G; Hayes R; Mullan MJ
    Brain Res; 2007 Dec; 1185():45-58. PubMed ID: 17961517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic effects of glatiramer acetate and grafted CD115⁺ monocytes in a mouse model of Alzheimer's disease.
    Koronyo Y; Salumbides BC; Sheyn J; Pelissier L; Li S; Ljubimov V; Moyseyev M; Daley D; Fuchs DT; Pham M; Black KL; Rentsendorj A; Koronyo-Hamaoui M
    Brain; 2015 Aug; 138(Pt 8):2399-422. PubMed ID: 26049087
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First effects of rising amyloid-β in transgenic mouse brain: synaptic transmission and gene expression.
    Cummings DM; Liu W; Portelius E; Bayram S; Yasvoina M; Ho SH; Smits H; Ali SS; Steinberg R; Pegasiou CM; James OT; Matarin M; Richardson JC; Zetterberg H; Blennow K; Hardy JA; Salih DA; Edwards FA
    Brain; 2015 Jul; 138(Pt 7):1992-2004. PubMed ID: 25981962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prenatal hypoxia may aggravate the cognitive impairment and Alzheimer's disease neuropathology in APPSwe/PS1A246E transgenic mice.
    Zhang X; Li L; Zhang X; Xie W; Li L; Yang D; Heng X; Du Y; Doody RS; Le W
    Neurobiol Aging; 2013 Mar; 34(3):663-78. PubMed ID: 22795785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
    van Groen T; Kiliaan AJ; Kadish I
    Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the origin of Alzheimer's disease. Trials and tribulations of the amyloid hypothesis.
    Castello MA; Soriano S
    Ageing Res Rev; 2014 Jan; 13():10-2. PubMed ID: 24252390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early formation of mature amyloid-beta protein deposits in a mutant APP transgenic model depends on levels of Abeta(1-42).
    Rockenstein E; Mallory M; Mante M; Sisk A; Masliaha E
    J Neurosci Res; 2001 Nov; 66(4):573-82. PubMed ID: 11746377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-Term Treatment with Liraglutide, a Glucagon-Like Peptide-1 (GLP-1) Receptor Agonist, Has No Effect on β-Amyloid Plaque Load in Two Transgenic APP/PS1 Mouse Models of Alzheimer's Disease.
    Hansen HH; Fabricius K; Barkholt P; Kongsbak-Wismann P; Schlumberger C; Jelsing J; Terwel D; Termont A; Pyke C; Knudsen LB; Vrang N
    PLoS One; 2016; 11(7):e0158205. PubMed ID: 27421117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid-beta and synaptic activity in mice and men.
    Ihara M; Kalaria RN
    Neuroreport; 2007 Aug; 18(12):1205-6. PubMed ID: 17632268
    [No Abstract]   [Full Text] [Related]  

  • 16. The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer's disease are associated with improved behavioral performance.
    Rockenstein E; Adame A; Mante M; Moessler H; Windisch M; Masliah E
    J Neural Transm (Vienna); 2003 Nov; 110(11):1313-27. PubMed ID: 14628195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective role of MMP-9 overexpression in the brain of Alzheimer's 5xFAD mice.
    Fragkouli A; Tsilibary EC; Tzinia AK
    Neurobiol Dis; 2014 Oct; 70():179-89. PubMed ID: 25008761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of CRFR1 Ablation on Amyloid-β Production and Accumulation in a Mouse Model of Alzheimer's Disease.
    Campbell SN; Zhang C; Roe AD; Lee N; Lao KU; Monte L; Donohue MC; Rissman RA
    J Alzheimers Dis; 2015; 45(4):1175-84. PubMed ID: 25697705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient near-infrared in vivo imaging of amyoid-β deposits in Alzheimer's disease mouse models.
    Schmidt A; Pahnke J
    J Alzheimers Dis; 2012; 30(3):651-64. PubMed ID: 22460331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cat and mouse.
    Cole GM; Frautschy SA
    Neuron; 2006 Sep; 51(6):671-2. PubMed ID: 16982408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.